Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway

Experimental and Therapeutic Medicine

Volumn 8, Issue 3, 2014, Pages 973-977

  Yuan, Xun ^a   Jing, Songbo ^a   Wu, Lingzhen ^a   Chen, Lianglong ^a   Fang, Jun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Mitochondrial permeability transition; Myocardial infarction; Phosphatidylinositol 3 kinase; Postconditioning; Reperfusion injury; Tanshinone IIA

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; TANSHINONE IIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; DRUG MEGADOSE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; LOW DRUG DOSE; MALE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; NONHUMAN; OPTICAL DENSITY; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

EID: 84904399099     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1820     Document Type: Article

References (25)

1. Braunwald E and Kloner RA: Myocardial reperfusion: a double-edged sword? J Clin Invest 76: 1713-1719, 1985.
2. Murry CE, Jennings RB and Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
3. Maulik N, Engelman RM, Wei Z, et al: Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. Circulation 88: II387-II394, 1993.
4. Zhao ZQ, Corvera JS, Halkos ME, et al: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588, 2003.
5. Tissier R, Waintraub X, Couvreur N, et al: Pharmacological postconditioning with the phytoestrogen genistein. J Mol Cell Cardiol 42: 79-87, 2007.
6. Gao S, Liu Z, Li H, et al: Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis 220: 3-10, 2012.
7. Xu W, Yang J and Wu LM: Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Pharmazie 64: 332-336, 2009.
8. Tsang A, Hausenloy DJ, Mocanu MM and Yellon DM: Postconditioning: a form of 'modified reperfusion' protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95: 230-232, 2004.
9. Lim SY, Davidson SM, Hausenloy DJ and Yellon DM: Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 75: 530-535, 2007.
10. Fang J, Chen L, Wu L and Li W: Intra-cardiac remote ischemic post-conditioning attenuates ischemia-reperfusion injury in rats. Scand Cardiovasc J 43: 386-394, 2009.
11. Fang J, Wu L and Chen L: Postconditioning attenuates cardiocyte ultrastructure injury and apoptosis by blocking mitochondrial permeability transition in rats. Acta Cardiol 63: 377-387, 2008.
12. Wang G, Liem DA, Vondriska TM, et al: Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 288: H1290-H1295, 2005.
13. Baines CP, Song CX, Zheng YT, et al: Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92: 873-880, 2003.
14. Hausenloy DJ and Yellon DM: New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61: 448-460, 2004.
15. Yellon DM and Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 357: 1121-1135, 2007.
16. Fu J, Huang H, Liu J, et al: Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 568: 213-221, 2007.
17. Tu EY, Zhou YG, Wang ZH, Liang QS and Yang GT: Effects of tanshinone II A on the myocardial hypertrophy signal transduction system protein kinase B in rats. Chin J Integr Med 15: 365-370, 2009.
18. Shan H, Li X, Pan Z, et al: Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1. Br J Pharmacol 158: 1227-1235, 2009.
19. Pan C, Lou L, Huo Y, et al: Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways. Ther Adv Cardiovasc Dis 5: 99-111, 2011.
20. Zhang Y, Wei L, Sun D, et al: Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats. Diabetes Obes Metab 12: 316-322, 2010.
21. Gao F, Gao E, Yue TL, et al: Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105: 1497-1502, 2002.
22. Halestrap AP, Kerr PM, Javadov S and Woodfield KY: Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366: 79-94, 1998.
23. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E and Ovize M: PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 69: 178-185, 2006.
24. Argaud L, Gateau-Roesch O, Raisky O, et al: Postconditioning inhibits mitochondrial permeability transition. Circulation 111: 194-197, 2005.
25. Zhang SZ, Ye ZG, Xia Q, Zhang W and Bruce I: Inhibition of mitochondrial permeability transition pore: A possible mechanism for cardioprotection conferred by pretreatment with tanshinone IIA. Conf Proc IEEE Eng Med Biol Soc 3: 2276-2279, 2005.